Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 0 |
Since 2016 (last 10 years) | 1 |
Since 2006 (last 20 years) | 2 |
Descriptor
Attention Deficit… | 2 |
Rating Scales | 2 |
Sexuality | 2 |
Symptoms (Individual… | 2 |
Age Differences | 1 |
Alcohol Abuse | 1 |
Behavior Problems | 1 |
College Athletics | 1 |
College Students | 1 |
Comparative Analysis | 1 |
Conceptual Tempo | 1 |
More ▼ |
Author
Adler, Lenard | 1 |
Anastopoulos, Arthur D. | 1 |
DuPaul, George J. | 1 |
Durell, Todd | 1 |
Paczkowski, Martin | 1 |
Pollack, Brittany | 1 |
Schuh, Kory | 1 |
Weysandt, Lisa L. | 1 |
Wilens, Timothy | 1 |
Publication Type
Journal Articles | 2 |
Reports - Research | 2 |
Education Level
Higher Education | 1 |
Postsecondary Education | 1 |
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
Conners Rating Scales | 2 |
What Works Clearinghouse Rating
Pollack, Brittany; DuPaul, George J.; Weysandt, Lisa L.; Anastopoulos, Arthur D. – Journal of Postsecondary Education and Disability, 2018
Young adults with attention-deficit/hyperactivity disorder (ADHD) symptoms are more likely than their peers to engage in risk-taking behaviors, including harmful alcohol use, consumption of illicit drugs, and risky sexual behaviors. These behaviors become more common in the general population of young adults as they enter college, particularly for…
Descriptors: Group Membership, Risk, Health Behavior, Attention Deficit Hyperactivity Disorder
Durell, Todd; Adler, Lenard; Wilens, Timothy; Paczkowski, Martin; Schuh, Kory – Journal of Attention Disorders, 2010
Objective: Atomoxetine is a nonstimulant medication for treating child, adolescent, and adult ADHD. This meta-analysis compared the effects in younger and older adults. Method: A post hoc analysis was conducted using data from two double-blind, placebo-controlled clinical trials. Data from patients aged 18-25 years were compared with data from…
Descriptors: Rating Scales, Older Adults, Patients, Effect Size